Literature DB >> 24310355

Tumor acidity as evolutionary spite.

Khalid O Alfarouk1, Abdel Khalig Muddathir, Mohammed E A Shayoub.   

Abstract

Most cancer cells shift their metabolic pathway from a metabolism reflecting the Pasteur-effect into one reflecting the Warburg-effect. This shift creates an acidic microenvironment around the tumor and becomes the driving force for a positive carcinogenesis feedback loop. As a consequence of tumor acidity, the tumor microenvironment encourages a selection of certain cell phenotypes that are able to survive in this caustic environment to the detriment of other cell types. This selection can be described by a process which can be modeled upon spite: the tumor cells reduce their own fitness by making an acidic environment, but this reduces the fitness of their competitors to an even greater extent. Moreover, the environment is an important dimension that further drives this spite process. Thus, diminishing the selective environment most probably interferes with the spite process. Such interference has been recently utilized in cancer treatment.

Entities:  

Year:  2011        PMID: 24310355      PMCID: PMC3756368          DOI: 10.3390/cancers3010408

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


Cancer Metabolism Creates an Acidic Environment

Both cancer and normal cells depend mainly on glucose metabolism to generate ATP to carry out normal maintenance and proliferation, where the initial steps of glucose metabolism result in the formation of pyruvate and generate two moles of ATP per mole of glucose. Switching from aerobic to anaerobic metabolism in the absence of oxygen is termed the Pasteur-effect [1]. Alternatively, under anaerobic conditions, pyruvate is converted to lactic acid. This is typically observed clinically in skeletal muscles during severe exercise where oxygen concentrations are exhausted and glucose metabolism is limited to the conversion to lactic acid. Nearly 100 years ago, Otto Warburg first observed that cancer cells metabolize glucose to lactate even in presence of oxygen—an observation that has been repeatedly confirmed and is now termed the Warburg effect [2]. Since the end product is lactic acid and because the reduced efficiency in ATP conversion requires increased glucose flux, the up-regulation of glycolysis in normal or cancer cells creates an acidic interstitial/extracellular environment [3]. These observations create a conundrum. It is widely assumed that the malignant phenotype arises through a process that is formally analogous to Darwinian evolution. Thus, if cancer results from prolonged “somatic evolution”, then any common phenotypic property observed in a malignant cell must confer a fitness advantage. On the contrary, aerobic glycolysis would confer two significant proliferative disadvantages: (1) It is significantly (18-fold!) less efficient than oxidative metabolism in producing energy, thus requiring far greater glucose uptake and use; and, (2) It produces a significantly acidic microenvironment that is toxic to mammalian cells. When combined with hypoxia, this metabolic microenvironment becomes quite caustic. Here, we propose that aerobic glycolysis confers an evolutionary advantage due to an adaptive strategy that is commonly termed “spite”. In brief, an organism can evolve a less fit phenotype only if it alters the local adaptive landscape in such a way that it reduces the fitness of all competing populations even more. So, cancer cells, as actors, increase their fitness compared to normal cells as recipients. The acidic environment will select for acid-adapted phenotypes not the glycolytic phenotype. Only after this adaptation will the glycolytic phenotype confer an advantage. This combination of phenotypes then confers an advantage because it increases extracellular matrix (ECM) degradation to facilitate invasion, induces death in normal cells, increases vascular endothelial growth factor (VEGF) release, and reduces the effectiveness of cytotoxic T cells in generating an immune response to tumor antigens. In this general theory, there has developed two types of spites: (i) Hamiltonian spite and (ii) Wilsonian spite, which is a modified Hamiltonian spite because he added a third party that gains benefit or costs the interaction of actor and recipient [4] that could be represented by the immune system in our model (z-axis) (see Figure 1). Here, we propose the environment as an additional fourth dimension because spite might not occur in the absence of a suitable environment (see Figure 2a).
Figure 1.

A comparison between the interaction spaces presented by the spite models proposed by Hamilton (left panel) and Wilson (right panel). Mutualism could be represented through the support of tumor growth by nonmalignant cells [30]. Moreover, some cancer cells become addicted to InterLeukin-3 to survive (primed cell for death) and so benefit from the immune system, and this is a kind of selfishness [31]. Yet, microenvironment acidity-induced cancer spite (MAICS) results in excessive cell death and eventually might prevent its spreadability and so it lies under the altruism umbrella because it results in an encapsulated tumor [32]. Cannibalism at the end results in death of both normal and malignant cells under the context of organismal selection so it is compatible with spite. Therefore, it would be very interesting if further studies carry on for determining how tumors handle the thresholds of the four quadrants.

Figure 2.

Here we propose a hypothetical model in which the environment where the player interactions are carried out (i.e., the acidic extracellular space; blue background) can play an important role in determining the choice and dynamics of spite. At this point, it is not possible to determine if there is a space-time quadrant where the environment has a greater or lesser effect and this will be an interesting point for future research. (a) Because microenvironment acidity-induced cancer spite (MAICS) blunts the immune system [33], interference with MAICS would probably create a shifting to Wilsonian spite. Thus, the third party reappears (Z-axis in (b) (Wilsonian spite) (b) This kind of shifting does not misconstrue to malignant and normal cells only but a spite process could happen also between secondary tumor cells (cannibal cells) and primary tumor cells.

Consequences of Microenvironment Acidity

It seems that carcinogenesis can undergo a positive feedback mechanism (control) and/or propagation reaction where once acidity appears around the cell, the tumor microenvironment become hostile, which could be seen as a point of no return. This acidic microenvironment selects pre-malignant (actor) glycolytic traits that adapt in the acidic microenvironment with normal cells (recipient) and, in this way; the acidic microenvironment produces Hamiltonian spite (Selfishness). In a positive feed-back cycle, these glycolytic traits then aggravate the microenvironment acidity that selectively increases the malignant phenotype. This hostile microenvironment selects more virulent types of cells expressing invasion promoting traits such as degradation of ECM, activation of VEGF, carbonic anhydrase [5,6], lactate dehydrogenase, cathepsin B and matrix metalloproteinases MMP-2 and MMP-9 [7,8]. Moreover, the acidic microenvironment inhibits the immune response [9]. Finally, the acidic microenvironment generates extremely virulent cell types that can phagocytosize stroma, normal cells, sibling cancer cells, yeast, etc., in a process called Cannibalism [10]. Cannibalism is a characteristic of secondary tumors, not primary tumors, and it occurs when malignant cells face starvation (low nutrients level), i.e., shifting from the Warburg-effect into Cannibalism. Cannibalism, as an indicator of reverse evolution of cancer [11-13], represents an additional tool of spite by increasing fitness; under starvation conditions cancer cells acquire the life style to survive, normal cells die. Thus, tumor cannibalism is a second tool of spite when the Warburg-effect does not reconcile with this starved environment. We do not know if tumor dormancy could represent an additional spite model or not if we compare it with normal cells under a high caustic environment due to tumor acidity or chemotherapy. Because metastases is an efficient process [14], tumor spite represents a successful strategy for tumor survival. The interaction of the cannibal cell (actor) alone with the recipient cell could be described as an example of Hamiltonian spite (selfishness). Interestingly, this Hamiltonian spite could be expanded to Wilsonian spite, where the primary tumor (third party) obtains additional beneficial effects from such a suppression of immune cells. Hence, tumor acidity might represent an attractive model for mixed types of spite. In this way, alteration of the acidic microenvironment eventually results in catastrophic dismantling carcinogenesis cascade (Gatenby-Gillies' Model) [15] via a positive feedback loop that finally results in spite. We suggest the term “microenvironment acidity-induced cancer spite (MAICS)” to define this acidic microenvironment-driven spite cascade (see Figure 2b).

Interference with MAICS (Anti-MAICS)

Recently, the targeting of MAICS (microenvironment acidity-induced cancer spite) has been suggested to be an attractive strategy in the war against cancer [16] that could most probably be achieved by the simultaneous use of several chemotherapeutic agents including: Proton Pump Inhibitors (PPIs) [17,18], bicarbonate (HCO3-), carbonic anhydrase inhibitors e.g., Acetazolamide [19-21], Na+-H+ exchanger inhibitors e.g., Amiloride [22-24], H+- ATP Synthase inhibitors e.g., Resveratrol [25-27]. Furthermore, spite represents a successful strategy in the generation of resistance [28], so once again MAICS would be an attractive target against chemotherapeutic resistance [29]

Conclusions

Our hypothesis is that the Warburg effect and tumor cannibalism are evolutionary consequences of a process termed ‘spite’, which arises through a series of steps in carcinogenesis. Thus, the tumor microenvironment is a suitable medium created to carry out these steps that provide tumor cells fitness and, in this context, targeting the tumor microenvironment represents a novel and potentially useful strategy in cancer therapy.
  31 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

Review 3.  Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.

Authors:  S Fais
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 4.  Evolution of cooperation among tumor cells.

Authors:  Robert Axelrod; David E Axelrod; Kenneth J Pienta
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 5.  The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.

Authors:  Salvador Harguindey; Gorka Orive; José Luis Pedraz; Angelo Paradiso; Stephan J Reshkin
Journal:  Biochim Biophys Acta       Date:  2005-09-25

Review 6.  Proton pump inhibitors may reduce tumour resistance.

Authors:  Angelo De Milito; Stefano Fais
Journal:  Expert Opin Pharmacother       Date:  2005-06       Impact factor: 3.889

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  A carbonic anhydrase inhibitor as a potential modulator of cancer therapies.

Authors:  B A Teicher; S D Liu; J T Liu; S A Holden; T S Herman
Journal:  Anticancer Res       Date:  1993 Sep-Oct       Impact factor: 2.480

Review 9.  Tumor acidity, chemoresistance and proton pump inhibitors.

Authors:  Angelo De Milito; Stefano Fais
Journal:  Future Oncol       Date:  2005-12       Impact factor: 3.404

Review 10.  Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies.

Authors:  Mareike Kelkel; Claus Jacob; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2010-10-12       Impact factor: 4.411

View more
  29 in total

1.  Screening of novel inhibitors targeting lactate dehydrogenase A via four molecular docking strategies and dynamics simulations.

Authors:  Rong Sun; Xin Li; Yuanyuan Li; Xun Zhang; Xinru Li; Xiaoyu Li; Zheng Shi; Jinku Bao
Journal:  J Mol Model       Date:  2015-05-02       Impact factor: 1.810

2.  Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells.

Authors:  Fang Zhou; Jin Du; Jianjun Wang
Journal:  Mol Cell Biochem       Date:  2017-01-07       Impact factor: 3.396

3.  Selenocystine-induced cell apoptosis and S-phase arrest inhibit human triple-negative breast cancer cell proliferation.

Authors:  Meijun Long; Juekun Wu; Junwen Hao; Wei Liu; Yong Tang; Xi Li; Hang Su; Wanshou Qiu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-21       Impact factor: 2.416

Review 4.  Cell-in-Cell Events in Oral Squamous Cell Carcinoma.

Authors:  Leonardo de Oliveira Siquara da Rocha; Bruno Solano de Freitas Souza; Daniel W Lambert; Clarissa de Araújo Gurgel Rocha
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

5.  Human monocytes differentiate into tumor-associated macrophages upon SKOV3 cells coculture and/or lysophosphatidic acid stimulation.

Authors:  Ying Feng; Meizhu Xiao; Guangming Cao; Hao Liu; Yanfang Li; Shuzhen Wang; Stan Zijtveld; Bert Delvoux; Sofia Xanthoulea; Andrea Romano; Chongdong Liu; Zhenyu Zhang
Journal:  J Inflamm (Lond)       Date:  2022-07-16       Impact factor: 6.283

6.  GLUT1 production in cancer cells: a tragedy of the commons.

Authors:  Anuraag Bukkuri; Robert A Gatenby; Joel S Brown
Journal:  NPJ Syst Biol Appl       Date:  2022-06-29

7.  A general reaction-diffusion model of acidity in cancer invasion.

Authors:  Jessica B McGillen; Eamonn A Gaffney; Natasha K Martin; Philip K Maini
Journal:  J Math Biol       Date:  2013-03-28       Impact factor: 2.259

Review 8.  Of mitochondrion and COVID-19.

Authors:  Khalid Omer Alfarouk; Sari T S Alhoufie; Abdelhameed Hifny; Laurent Schwartz; Ali S Alqahtani; Samrein B M Ahmed; Ali M Alqahtani; Saad S Alqahtani; Abdel Khalig Muddathir; Heyam Ali; Adil H H Bashir; Muntaser E Ibrahim; Maria Raffaella Greco; Rosa A Cardone; Salvador Harguindey; Stephan Joel Reshkin
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 9.  Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.

Authors:  Di Chang; Yuanyuan Ma; Xiaoxuan Xu; Jinbing Xie; Shenghong Ju
Journal:  Front Bioeng Biotechnol       Date:  2021-06-25

10.  Riparian ecosystems in human cancers.

Authors:  Khalid O Alfarouk; Muntaser E Ibrahim; Robert A Gatenby; Joel S Brown
Journal:  Evol Appl       Date:  2012-10-10       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.